Effects of Coenzyme Q10 on cognitive level of hemodialysis patients

Assessment of Coenzyme Q10 effects on cognitive level of hemodialysis patients in Kowsar hospital, Semnan, 2015

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014103019758N1

Enrollment

Registered

2014-12-25

Start date

2014-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive state. Mild cognitive disorder

Interventions

Patients in control group after mini-mental state examination will receive placebo for 90 days and after that mini-mental state examination will be carried out again.

Intervention 1: Patients in case group after mini-mental state examination will receive Coenzym Q10 daily 100 mg, after that mini-mental state examination will be carried out again. Intervention 2: Pa

Treatment - Drugs

Placebo

Patients in case group after mini-mental state examination will receive Coenzym Q10 daily 100 mg, after that mini-mental state examination will be carried out again.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients who undergoing hemodialysis. Exclusion criteria: None

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Cognitive state. Timepoint: 90 Days after intervention. Method of measurement: Interview and standars questionnaire Mini-mental state examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrdad Zahmatkesh

Semnan University of Medical Sciences

mehrdadzahmatkesh@semums.ac.ir+98 23 3343 7822

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026